Olaparib in Metastatic Castration-Resistant Prostate Cancer

被引：0
|
作者：
Smith, Thomas J. [1 ]
机构：
[1] Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2021年 / 384卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1175 / 1175
页数：1
相关论文
共 50 条
  • [31] Bipolar androgen therapy (BAT) plus olaparib in men with metastatic castration-resistant prostate cancer (mCRPC)
    Schweizer, M.
    Gulati, R.
    Yezefski, T.
    Cheng, H.
    Sievers, C.
    Dumpit, R.
    Alexander, K.
    McDonald, N.
    Lai, M.
    Nega, K.
    Hammond, J.
    Grivas, P.
    Hsieh, A.
    Montgomery, B.
    Nelson, P.
    Yu, E.
    ANNALS OF ONCOLOGY, 2021, 32 : S639 - S640
  • [32] Abiraterone in the treatment of metastatic castration-resistant prostate cancer
    Mostaghel, Elahe A.
    CANCER MANAGEMENT AND RESEARCH, 2014, 6 : 39 - 51
  • [33] Immune Biomarkers in Metastatic Castration-resistant Prostate Cancer
    de la Maza, Maria Dolores Fenor
    Chandran, Khobe
    Rekowski, Jan
    Shui, Irene M.
    Gurel, Bora
    Cross, Emily
    Carreira, Suzanne
    Yuan, Wei
    Westaby, Daniel
    Miranda, Susana
    Ferreira, Ana
    Seed, George
    Crespo, Mateus
    Figueiredo, Ines
    Bertan, Claudia
    Gil, Veronica
    Riisnaes, Ruth
    Sharp, Adam
    Rodrigues, Daniel Nava
    Rescigno, Pasquale
    Tunariu, Nina
    Liu, Xiao Qiao
    Cristescu, Razvan
    Schloss, Charles
    Yap, Christina
    Bono, Johann S. de
    EUROPEAN UROLOGY ONCOLOGY, 2022, 5 (06): : 659 - 667
  • [34] Trial design for metastatic castration-resistant prostate cancer
    Sonpavde, Guru
    Fleming, Mark T.
    Hutson, Thomas E.
    Galsky, Matthew D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (21) : 3647 - 3648
  • [35] Contemporary management of metastatic castration-resistant prostate cancer
    Sonpavde, Guru
    Sternberg, Cora N.
    CURRENT OPINION IN UROLOGY, 2011, 21 (03) : 241 - 247
  • [36] Drug therapies for metastatic castration-resistant prostate cancer
    El-Bahesh, Ehab
    Finianos, Antoine
    Alfaraj, Abeer
    Aragon-Ching, Jeanny B.
    FUTURE ONCOLOGY, 2015, 11 (17) : 2395 - 2403
  • [37] Olaparib plus Abiraterone for Metastatic Castration-resistant Prostate Cancer: Pharmacokinetics Data from the PROpel Trial
    Armstrong, Andrew J.
    Clarke, Noel
    Oya, Mototsugu
    Procopio, Giuseppe
    de Menezes, Juliana
    Guedes, Joao Daniel
    Ghatalia, Pooja
    Nole, Franco
    Din, Omar
    Spiegelhalder, Philipp
    Mincik, Ivan
    van Alphen, Robbert
    Lumen, Nicolaas
    Hosius, Christian
    Zhou, Diansong
    Barker, Laura
    Dujka, Melanie
    Saad, Fred
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (02): : 292 - 296
  • [38] Histologic Spetrum of Metastatic Castration-Resistant Prostate Cancer
    Huang, Jiaoti
    Yin, Yu
    Thomas, George
    True, Lawrence
    Beer, Tomasz M.
    Gleeve, Martin
    Witte, Owen
    Stuart, Josh
    Evans, Chris
    Foye, Adam
    Youngren, Jack
    Small, Eric
    LABORATORY INVESTIGATION, 2017, 97 : 231A - 231A
  • [39] The obesity paradox in metastatic castration-resistant prostate cancer
    Martini, Alberto
    Shah, Qainat N.
    Waingankar, Nikhil
    Sfakianos, John P.
    Tsao, Che-Kai
    Necchi, Andrea
    Montorsi, Francesco
    Gallagher, Emily J.
    Galsky, Matthew D.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2022, 25 (03) : 472 - 478
  • [40] Drug resistance in metastatic castration-resistant prostate cancer
    Bostjan Seruga
    Alberto Ocana
    Ian F. Tannock
    Nature Reviews Clinical Oncology, 2011, 8 : 12 - 23
12345